Argentina vs Netherlands: Proportion of isolates with decreased susceptibility or resistance
Argentina
0
in 2018
Netherlands
0
in 2018
Argentina rank
25th
Netherlands rank
25th
Proportion of isolates with decreased susceptibility or resistance over time
- Argentina
- Netherlands
How they compare
Argentina currently reports 0 against 0 in Netherlands, a difference of 0.
The two have swapped places 2 times across 10 shared years of data; in 2009 it was Netherlands ahead.
Argentina ranks 25th and Netherlands ranks 25th of 51 countries.
Netherlands has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Argentina | Netherlands | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0 | 0 | 0 | — |
| 2010s | 0.0316 | 0.6065 | 0.5749 | Netherlands |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of isolates with decreased susceptibility or resistance, Argentina or Netherlands?
- Argentina, at 0 against 0 in Netherlands as of 2018.
- What is the difference in proportion of isolates with decreased susceptibility or resistance between Argentina and Netherlands?
- 0, with Argentina ahead.
- How many years of comparable data are there for Argentina and Netherlands?
- 10 years are reported by both, from 2009 to 2018.
- How do Argentina and Netherlands rank globally for proportion of isolates with decreased susceptibility or resistance?
- Argentina ranks 25th and Netherlands ranks 25th of 51 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Proportion of isolates with decreased susceptibility or resistance (DS/R) to extended-spectrum cephalosporins reported to WHO-GASP. Statizoid refreshes it automatically from the source and publishes the full history for both places.